TARRYTOWN, N.Y., March 1 /PRNewswire-FirstCall/ -- Emisphere Technologies,
Inc. (Nasdaq: EMIS), today announced that it will participate in the SG Cowen
& Co. 26th Annual Health Care Conference, being held at The Marriott Copley
Place in Boston. Michael M. Goldberg, M.D., Chairman and Chief Executive
Officer, will present on Monday, March 6, 2006, at 4:50 p.m. EST.
The presentation will be broadcast live via the Internet. You may access
the presentation by visiting the investor relations portion within the
Emisphere Technologies web site http://www.emisphere.com/ir.asp or directly at:
http://www.corporate-ir.net/ireye/confLobby.zhtml?ticker=EMIS&item_id=1221669
Please visit the site at least five minutes prior to start time for
instructions. A replay will be available approximately one hour after webcast
presentation through June 6, 2006. Corresponding slides will also be posted to
the Investor Relations portion of Emisphere's web site.
About Emisphere Technologies, Inc.
Emisphere Technologies, Inc. is a biopharmaceutical company pioneering the
oral delivery of otherwise injectable drugs. Emisphere's business strategy is
to develop oral forms of injectable drugs, either alone or with corporate
partners, by applying its proprietary eligen(R) technology to those drugs or
licensing its eligen(R) technology to partners who typically apply it directly
to their marketed drugs. Emisphere's eligen(R) technology has enabled the oral
delivery of proteins, peptides, macromolecules and charged organics. Emisphere
and its partners have advanced oral formulations or prototypes of salmon
calcitonin, heparin, insulin, parathyroid hormone, human growth hormone and
cromolyn sodium into clinical trials. Emisphere has strategic alliances with
world-leading pharmaceutical companies. For further information, please visit
http://www.emisphere.com.
SOURCE Emisphere Technologies, Inc.
 back to top
Related links:
http://www.emisphere.com
CONTACT:
Elliot M. Maza, Chief Financial Officer of
Emisphere Technologies, Inc., +1-914-785-4703
|
